● Recruiting

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older

Condition: Malaria, Vivax · Sponsor: GlaxoSmithKline

PhasePhase 3

Planned participants300

Who can joinAll sexes, 2 Years to 64 Years

Healthy volunteersNo

About this study

The aim of this study is to collect efficacy and safety data to support the registration of tafenoquine in India.

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (4)

GSK Investigational Site	Ahmedabad, India	Recruiting
GSK Investigational Site	Kolkata, India	Recruiting
GSK Investigational Site	Mumbai, India	Recruiting
GSK Investigational Site	Surat, India	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06666491